Journals / İmgelem / 2022 / Cilt: 6 Sayı: 10

THE SHIFT FROM INTERNATIONAL TO GLOBAL HEALTH POLICY: ACTORS, FRAMEWORKS, AND CHALLENGES

ULUSLARARASI SAĞLIK POLITIKASINDAN KÜRESEL SAĞLIK POLITIKASINA GEÇIŞ: AKTÖRLER, ÇERÇEVELER VE ZORLUKLAR

Journal
İmgelem
Pages
277–294
Publication Date
2022-07-15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These challenges are neglected tropical diseases (NTD), social determinants of health (SDH), public private partnerships (PPP), and intellectual property rights (IPR).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:During the last two decades, particularly with the acceleration of globalization, there has been a proliferation of new actors in the field of global health.
📊
Key Findings & Data:This resulted in a shift from international health governance (IHG) model, which recognizes nation state as the core actor, to global health governance (GHG) model, which incorporates civil society organizations and businesses.
💡
Conclusion & Impact:These challenges are neglected tropical diseases (NTD), social determinants of health (SDH), public private partnerships (PPP), and intellectual property rights (IPR).
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:küresel sağlık · kamu sağlığı · politika

Abstract

During the last two decades, particularly with the acceleration of globalization, there has been a proliferation of new actors in the field of global health. This resulted in a shift from international health governance (IHG) model, which recognizes nation state as the core actor, to global health governance (GHG) model, which incorporates civil society organizations and businesses. This article will explore this shift from IHG to GHG from multiple angles. It will first shed light on the historical origins of this phenomenon and then analyze the role of each actor that constitute these models. This will be followed by an assessment of the tension between vertical and horizontal approaches to global health policy. The article will finally underline the main challenges that are ahead of global health governance. These challenges are neglected tropical diseases (NTD), social determinants of health (SDH), public private partnerships (PPP), and intellectual property rights (IPR).

Özet

Son yirmi yıldır, özellikle küreselleşmenin hız kazanması ile birlikte, küresel sağlık alanındaki aktörlerin sayısı da çoğalmıştır. Böylece ulus devlet odaklı işleyen uluslararası sağlık yönetiminin (IHG) yerini, sivil toplum örgütlerini ve şirketleri bünyesine katmayı başaran küresel sağlık yönetimi (GHG) almıştır. Bu çalışma IHG modelinden GHG modeline yapılan bu geçişi farklı yönleriyle ele alacaktır. İlk olarak bu değişimin tarihsel arka planına ışık tutacak, sonra da bu iki modeli oluşturan aktörlerin rollerini inceleyecektir. Buna bağlı olarak küresel sağlık politikalarda dikey ve yatay modeller arasındaki gerilimi irdeleyecektir. Çalışma son olarak sağlık yönetiminin karşı karşıya olduğu zorlukların altını çizecektir. Bu zorluklar ihmal edilen tropikal hastalıklar (NTD), sağlığın sosyal belirleyicileri (SDH), kamu-özel ortaklıkları (PPP) ve fikri mülkiyet haklarıdır (IPR).

🔖

Cite This Article

GÜÇLER, A. (2022). THE SHIFT FROM INTERNATIONAL TO GLOBAL HEALTH POLICY: ACTORS, FRAMEWORKS, AND CHALLENGES. İmgelem, Cilt: 6 Sayı: 10, 277–294. https://ajindex.com/articles/906878

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. ‘t Hoen, E., Berger, J., Calmy, A., et. al. (2011). Driving a decade of change: HIV/AIDS, Patents, and Access to Medicine. Journal of the International AIDS Society, 14, 1 – 12. Aginam, O. (2005). Global Health Governance: International Law and Public Health in a Divided World. Toronto: University of Toronto Press.
  2. Balcius, J. and Novotny, T. E. (2011). New approaches to global health governance: The evolution to public-private partnerships. Journal of Commercial Biotechnology, 17, 233 – 240. Birn, A. and Lexchin, J. (2011) Beyond patents: The GAVI Alliance, AMCs and improving immunization coverage through public sector vaccine production in the global south, Human Vaccines, 7 (3), 291 – 292. Dudley, L. and Garner, P. (2011). Strategies for integrating primary health services in middle- and low-income countries at the point of delivery. Cochrane Database of Systematic Reviews, (7):CD003318. Brown, T. M., Cueto, M. and Fee, E. (2006). The World Health Organization and the transition from ‘international’ to ‘global’ public health. American Journal of Public Health, 96 (1), 62 – 72. Burrone, E., Gotham, D., Gray, et. al. (2019). Patent pooling to increase access to essential medicines. Bulletin of the World Health Organization, 97 (8), 575 – 577. Buse, K. and Walt, G. (2000). Role conflict? The World Bank and the world’s health. Social Science and Medicine, 50 (2), 169 – 176 Caines, K., Buse, K., Carlson, C., et al. (2004). Assessing the Impact of Global Health Partnerships. London: DFID Health Resource Centre. Cairncross, S., Peries, H. and Cutts, F. (1997). Vertical health programmes. Lancet, 349 (Suppl. III), 20 – 22. Castellani, A. and Chalmers, A. J. (1919). History of tropical medicine. In Manual of Tropical Medicine, 3rd ed. (pp. 3 – 38). New York: Wm Wood & Co. Chisholm, B. (1950). The World Health Organization. British Medical Journal, May 6, 4661- 1027. Cohen, J. (2006). The New World of Global Health. Science, 311 (January 13), 162 – 67. David, B. and Casady, C. B. (2020). Proactive and strategic healthcare public-private partnerships (PPPs) in the coronavirus (Covid-19) epoch. Sustainability, MDPI, Open access journal, 12 (12). Donkin, A., Goldblatt, P., Allen, J., et al. (2017). Global action on the social determinants of health. BMJ Glob Health, 1 – 17. Doyle, C. and Patel, P. (2008). Civil society organisations and global health initiatives: problems of legitimacy. Social Science and Medicine, 66 (9), 1928 – 1938.
  3. Engels, D. and Zhou, X. N. (20